Differentiation of vascular dementia from AD on neuropsychological tests.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 10953213)

Published in Neurology on August 22, 2000

Authors

D R Royall, G C Roman

Articles by these authors

Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm Suppl (2000) 2.56

Neuropsychiatric correlates and treatment of lenticulostriatal diseases: a review of the literature and overview of research opportunities in Huntington's, Wilson's, and Fahr's diseases. A report of the ANPA Committee on Research. American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1998) 2.28

Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: tract-based spatial statistics study of aging. Neuroimage (2006) 2.09

Multiple sclerosis or HTLV-I myelitis? Neurology (1990) 1.53

Therapy for neurocysticercosis: a reappraisal. Clin Infect Dis (1993) 1.24

Loss of cerebral white matter structural integrity tracks the gray matter metabolic decline in normal aging. Neuroimage (2008) 1.18

Risk factors for the onset of depression in middle age and later life. Soc Psychiatry Psychiatr Epidemiol (1993) 1.04

Natural history of spinal cord infarction caused by nucleus pulposus embolism. Spine (Phila Pa 1976) (1994) 1.03

Executive control function: a rational basis for the diagnosis of vascular dementia. Alzheimer Dis Assoc Disord (2000) 1.02

Comments on the executive control of clock-drawing. J Am Geriatr Soc (1996) 0.90

Optic and peripheral neuropathy in Cuba. JAMA (1994) 0.89

The use of herbal alternative medicines in neuropsychiatry. A report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci (2000) 0.86

EXIT, QED, and DSM-IV: very early Alzheimer's disease. J Neuropsychiatry Clin Neurosci (1994) 0.86

Qualitative assessment of dementia. J Am Geriatr Soc (1994) 0.84

BIOSSIM--a structured machine-independent biological simulation language. Comput Biomed Res (1978) 0.83

Cysticercosis. Curr Clin Top Infect Dis (1996) 0.82

Brain infarction and the clinical expression of Alzheimer disease. JAMA (1997) 0.79

[Paraplegia associated with HTLV-1 virus]. Rev Neurol (Paris) (1989) 0.78

The FAB: a frontal assessment battery at bedside. Neurology (2001) 0.77

EXIT, QED, and DSM-IV: regional syndromes. J Neuropsychiatry Clin Neurosci (1994) 0.75

[On "Proposal for the application and scoring of the clock drawing test in Alzheimer's disease"]. Rev Neurol (2000) 0.75

ECF deficits and anorectic behavior. J Am Geriatr Soc (1991) 0.75

Cuban optic neuropathy. Neurology (1995) 0.75

Some "depressive" symptoms may not imply depression. J Am Geriatr Soc (1997) 0.75

Validating the GDS in a nursing home sample. J Am Geriatr Soc (1996) 0.75

HIV and HTLV-I antibody studies: pregnant women in the 1960s, patients with AIDS, homosexuals, and individuals with tropical spastic paraparesis. Yale J Biol Med (1988) 0.75

Assessment of treatment outcomes in neuropsychiatry: a report from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1995) 0.75

Pharmacologic efficacy in neuropsychiatry: a review of placebo-controlled treatment trials. A report of the ANPA Committee on Research. J Neuropsychiatry Clin Neurosci (1999) 0.75

[Epidemiological characteristics of Parkinson's disease in various areas in the world]. Zhonghua Liu Xing Bing Xue Za Zhi (1996) 0.75

The clinician-scientist in neuropsychiatry: a position statement from the Committee on Research of the American Neuropsychiatric Association. J Neuropsychiatry Clin Neurosci (1998) 0.75

Dopaminergic mediation of reward: evidence gained using a natural reinforcer in a behavioral contrast paradigm. Neurosci Lett (1981) 0.75

Vascular dementia: a time to 'seize the moment'. Neuroepidemiology (1993) 0.75